BlackRock Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.13M | Buy |
84,363
+35,823
| +74% | +$904K | ﹤0.01% | 1716 |
|
|
2016
Q3 | $1.2M | Buy |
48,540
+14,842
| +44% | +$367K | ﹤0.01% | 1920 |
|
|
2016
Q2 | $687K | Buy |
33,698
+2,316
| +7% | +$47.2K | ﹤0.01% | 2131 |
|
|
2016
Q1 | $479K | Sell |
31,382
-3,460
| -10% | -$52.8K | ﹤0.01% | 2246 |
|
|
2015
Q4 | $469K | Buy |
34,842
+7,834
| +29% | +$105K | ﹤0.01% | 2216 |
|
|
2015
Q3 | $379K | Sell |
27,008
-6,988
| -21% | -$98.1K | ﹤0.01% | 2294 |
|
|
2015
Q2 | $577K | Buy |
+33,996
| New | +$577K | ﹤0.01% | 2205 |
|